New drug VIP36 shows promise in treating pain without harmful side effects

biopharmadive.com

Center

Factuality

Ownership

Tris to ask for approval of dual-acting pain drug

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing medications, has a good shot at reaching market.

Le Point.fr

Lean Right

Factuality

Ownership

Faced with the opioid crisis that ravages the United States, research is intensifying to find alternatives. A French biotech could hold the revolutionary molecle.

Science Daily

Center

Factuality

Ownership

Compound harnesses cannabis' pain-relieving properties without side effects

Researchers have developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The custom-designed molecule, derived from cannabis, may provide an alternative to opioids for treating chronic pain.

News Medical

Center

Factuality

Ownership

New drug VIP36 shows promise in treating pain without harmful side effects

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.

csimarket.com

Factuality

Ownership

#Virpax Pharmaceuticals A Strategic Step Forward in Non-Addictive Pain Management

The Dawn of a New Era in Pain Management' At the intersection of medical innovation and societal need stands Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company that has set its sights on pioneering non-addictive treatments for an array of conditions including pain management, post-traumatic stress disorder (PTSD), central nervous system disorders, and viral infections. As societal concerns about the addiction epidemic continue to rise, parti…